Virometix AG, a clinical-stage biotechnology company based in Schlieren, Switzerland, has successfully completed a financing round totaling $15 million from existing shareholders. This funding...
A recent study published in Clinical Cancer Research highlights the potential of a new combination therapy for patients with chronic lymphocytic leukemia (CLL), the...
UPDATE: Scientists at the University of Maryland have just announced a groundbreaking vaccine that could protect against Salmonella, one of the leading causes of...